Hideaki Nakamura

Biomaterials · 2011–2013

A researcher in the Science corpus: 2 papers; trusts 1 researcher and is trusted by 6 researchers here, as inferred from the citation graph.

Subfields

Whom Hideaki Nakamura trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. H. Maeda

Who trusts Hideaki Nakamura overall

  1. M. Ernsting
  2. H. Maeda
  3. Jun Wu

Papers from Hideaki Nakamura's perspective

Ordered by how strongly the researchers Hideaki Nakamura trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Delivering nanomedicine to solid tumors (Nature Reviews Clinical Oncology)
  2. Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile (Science Translational Medicine)
  3. Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers. (Journal of Clinical Oncology)
  4. Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. (Progress in lipid research)
  5. Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. (Journal of Controlled Release)
  6. Targeting nanoparticles to cancer. (Pharmacological Research)
  7. Drug Delivery Systems: Entering the Mainstream (Science)
  8. Long-circulating and target-specific nanoparticles: theory to practice. (Pharmacological Reviews)
  9. Ligand-targeted therapeutics in anticancer therapy (Nature Reviews. Cancer)
  10. Challenges and key considerations of the enhanced permeability and retention (EPR) effect for nanomedicine drug delivery in oncology (Cancer Research)

Their papers